home / stock / bdrx / bdrx news


BDRX News and Press, Biodexa Pharmaceuticals PLC-ADR

Stock Information

Company Name: Biodexa Pharmaceuticals PLC-ADR
Stock Symbol: BDRX
Market: NASDAQ
Website: biodexapharma.com

Menu

BDRX BDRX Quote BDRX Short BDRX News BDRX Articles BDRX Message Board
Get BDRX Alerts

News, Short Squeeze, Breakout and More Instantly...

BDRX - Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer

MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST) Meg Flippin, Benzinga Staff Writer CARDIFF, UK / ACCESS Newswire / February 19, 2026 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical...

BDRX - Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

February 4, 2026 Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX Models Cardiff, UK – February 4, 2026 – Biodexa Pharmaceuticals P...

BDRX - Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developi...

BDRX - Biodexa Pharmaceuticals prices $10M best-efforts public offering; shares down

2025-12-18 08:43:23 ET More on Biodexa Pharmaceuticals Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals Financial information for Biodexa Pharmaceuticals Read the full article on Seeking Alpha For further details see: Biodexa Pharmaceuticals...

BDRX - Biodexa Announces Pricing of $10 Million Public Offering

December 18, 2025 Biodexa Announces Pricing of $10 Million Public Offering Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) (“Biodexa” or the “Company”), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of dise...

BDRX - US Companies Moving the Markets, Morning edition
Thu, Dec 11, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.8% to $2.82 on volume of 304,720,109 shares Heartbeam Inc. (BEAT) rose 92.4% to $1.55 on volume of 270,417,600 shares Agape ATP Corporation (ATPC) fell 94.8% to $0.068 on volume ...

BDRX - US Companies Moving the Markets, Evening edition
Wed, Dec 10, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.3% to $2.805 on volume of 252,611,029 shares Heartbeam Inc. (BEAT) rose 75.0% to $1.41 on volume of 230,579,770 shares Paranovus Entertainment Technology Ltd. (PAVS) fell 14.1% t...

BDRX - Biotech Breakthroughs & the Rise of Engineered Industries

2025-12-10 09:41:02 ET DENVER, Colo., Dec 10, 2025 ( 247marketnews.com )- The mid-week session opens with a sweeping slate of innovation-driven catalysts across biotechnology, engineered materials, medical devices, and specialty pharmaceuticals. From Kraig Labs’ quiet but histori...

BDRX - US Companies Moving the Markets, Morning edition
Wed, Dec 10, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Netcapital Inc. (NCPL) rose 112.5% to $1.4 on volume of 283,775,290 shares Paranovus Entertainment Technology Ltd. (PAVS) fell 11.7% to $0.0432 on volume of 243,787,566 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.0%...

BDRX - US Companies Moving the Markets, Evening edition
Tue, Dec 09, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Netcapital Inc. (NCPL) rose 105.0% to $1.3506 on volume of 269,304,576 shares Paranovus Entertainment Technology Ltd. (PAVS) fell 14.0% to $0.04205 on volume of 211,406,068 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose ...

Next 10